Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UMLS:C0684249 (
lung carcinoma
)
23,830
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
We have recently shown that transient expression of
10-formyltetrahydrofolate dehydrogenase
(
FDH
) strongly inhibits proliferation of several cancer cell lines and ultimately results in cell death. In the present studies using Tet-On system, we have generated a stable A549
lung carcinoma
cell line capable of inducible
FDH
expression. Using this system, we were able to express
FDH
at different levels depending on concentration of the inducer, doxycycline, and we have observed that inhibition of proliferation depends on
FDH
intracellular levels. We have further shown that induction of
FDH
expression results in initiation of apoptosis beginning 24 h post-induction. Apoptotic cells revealed cleavage of poly-(ADP-ribose) polymerase and general caspase inhibitor zVAD-fmk protected cells against
FDH
-induced apoptosis.
FDH
-expressing cells showed accumulation of cells in G(0)-G(1) phase and a sharp decrease of cells in S phase. Accumulation of intracellular
FDH
was followed by accumulation of the tumor suppressor protein p53 and its downstream target p21. These results indicate that
FDH
antiproliferative effects on A549 cells include both G(1) cell cycle arrest and caspase-dependent apoptosis.
...
PMID:Ectopic expression of 10-formyltetrahydrofolate dehydrogenase in A549 cells induces G1 cell cycle arrest and apoptosis. 1280 5